These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 22361915)

  • 1. Current treatment of peripheral T-cell lymphoma.
    Horwitz SM; Coiffier B; Hsi ED; Pro B
    Clin Adv Hematol Oncol; 2011 Aug; 9(8 Suppl 16):1-15. PubMed ID: 22361915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and pathological diagnosis of peripheral T-cell lymphoma and emerging treatment options: A case-based discussion.
    Said J; Pinter-Brown L
    Clin Adv Hematol Oncol; 2009 Nov; 7(11):S1, S4-13; quiz S15. PubMed ID: 20095101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of high-dose therapy in peripheral T-cell lymphomas.
    Reimer P; Rüdiger T; Wilhelm M
    Clin Lymphoma Myeloma; 2006 Mar; 6(5):373-9. PubMed ID: 16640812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic Cell Transplantation and Adoptive Cell Therapy in Peripheral T Cell Lymphoma.
    Rogers AM; Brammer JE
    Curr Hematol Malig Rep; 2020 Aug; 15(4):316-332. PubMed ID: 32529515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The aggressive peripheral T-cell lymphomas: 2015.
    Armitage JO
    Am J Hematol; 2015 Jul; 90(7):665-73. PubMed ID: 26031230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral T-cell lymphoma: a case-based discussion of recent advances in patient management.
    Franco CM; Popplewell LL; Horwitz SM
    Clin Adv Hematol Oncol; 2011 Apr; 9(4 Suppl 9):1-16. PubMed ID: 21559001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral T-cell lymphoma--not otherwise specified.
    Savage KJ; Ferreri AJ; Zinzani PL; Pileri SA
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):321-9. PubMed ID: 20702104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas.
    Blystad AK; Enblad G; Kvaløy S; Berglund A; Delabie J; Holte H; Carlson K; Kvalheim G; Bengtsson M; Hagberg H
    Bone Marrow Transplant; 2001 Apr; 27(7):711-6. PubMed ID: 11360110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose therapy and stem cell transplantation.
    Zinzani PL
    Semin Hematol; 2010 Apr; 47 Suppl 1():S15-7. PubMed ID: 20359581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic stem cell transplantation in the treatment of peripheral T-cell lymphomas.
    Majhail NS; Burns LJ
    Curr Hematol Rep; 2005 Jul; 4(4):252-9. PubMed ID: 16009039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01.
    d'Amore F; Relander T; Lauritzsen GF; Jantunen E; Hagberg H; Anderson H; Holte H; Österborg A; Merup M; Brown P; Kuittinen O; Erlanson M; Østenstad B; Fagerli UM; Gadeberg OV; Sundström C; Delabie J; Ralfkiaer E; Vornanen M; Toldbod HE
    J Clin Oncol; 2012 Sep; 30(25):3093-9. PubMed ID: 22851556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current state of art for transplantation paradigms in peripheral T-cell lymphomas.
    Perrone G; Farina L; Corradini P
    Expert Rev Hematol; 2013 Aug; 6(4):465-74. PubMed ID: 23991932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival.
    Kim MK; Kim S; Lee SS; Sym SJ; Lee DH; Jang S; Park CJ; Chi HS; Huh J; Suh C
    Ann Hematol; 2007 Jun; 86(6):435-42. PubMed ID: 17256144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and future aggressive peripheral T-cell lymphoma treatment paradigms, biological features and therapeutic molecular targets.
    Rodríguez J; Gutiérrez A; Martínez-Delgado B; Perez-Manga G
    Crit Rev Oncol Hematol; 2009 Sep; 71(3):181-98. PubMed ID: 19056295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral T-cell lymphomas, unspecified (or not otherwise specified): a review.
    Rodriguez-Abreu D; Filho VB; Zucca E
    Hematol Oncol; 2008 Mar; 26(1):8-20. PubMed ID: 18050364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Peripheral T-Cell Lymphoma: Many Shades of Gray.
    Lunning MA
    Oncology (Williston Park); 2015 Aug; 29(8):545-50. PubMed ID: 26281838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral T-cell lymphoma: autologous hematopoietic cell transplantation as first-line therapy.
    Laport GG
    Curr Opin Oncol; 2010 Sep; 22(5):409-13. PubMed ID: 20683269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral T-cell lymphoma: new therapeutic strategies.
    Petrich AM; Rosen ST
    Oncology (Williston Park); 2013 Sep; 27(9):878-84. PubMed ID: 24282984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation.
    Zain J
    Cancer Treat Res; 2019; 176():269-287. PubMed ID: 30596223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.